Higher yield potential of hybrid rice to help meet rice demands towards Indonesian Government’s goal of self-sufficiency
Bayer launches Arize® hybrid rice in Indonesia:
Bayer CropScience announces plans to launch its Arize® hybrid rice seeds in the Indonesian market, to help Indonesian rice farmers improve their productivity and yield, so as to meet local rice demands and help the government go one step closer towards its goal of achieving self-sufficiency in rice.
Ho Chi Minh City, Vietnam, October 15, 2015 – Bayer CropScience announces plans to launch its Arize® hybrid rice seeds in the Indonesian market, to help Indonesian rice farmers improve their productivity and yield, so as to meet local rice demands and help the government go one step closer towards its goal of achieving self-sufficiency in rice.
Indonesia is the world’s third largest producer of rice, and rice farming is the source of livelihood for over 30 million farmers. The country is also one of the world’s biggest consumers of rice, which is a key staple in the Indonesian diet. Currently, Indonesia’s rice harvest totals around 13 million hectares, representing 24 per cent of the country’s total agricultural area.
In the last few years, to meet the growing demands for rice, Indonesia has been a key importer of rice in the region. The Indonesian government has set a goal to work towards achieving self-sufficiency in rice, and to achieve this, its immediate focus is to look at improving the productivity and production of rice in the country. As hybrid rice has the potential to increase yields by 15 to 35 per cent over inbreds, the government is looking at hybrid rice as one of the key success factors to help them achieve their target.
Currently, hybrid rice is cultivated in only about 6 to 8 per cent of the rice areas, and there is much more potential to increase the adoption of hybrid rice. To this end, Bayer CropScience is pleased to announce the launch of its Arize hybrid rice seeds in the market. With immediate effect, Arize® 6444 will be available for sale. There are also plans to launch Arize® H6444 Gold, the first Bacteria Leaf Blight (BLB)-resistant hybrid, in Indonesia in the first quarter of next year.
With the introduction of Arize®, Bayer will offer a complete, integrated and innovative solution in rice, including hybrid rice seeds, crop protection offerings and training, which will be known to farmers as Bayer Padi Plus – a holistic and integrated approach to rice production that provides higher yields and revenues to farmers.
“Bayer CropScience is committed to continuously introduce innovative solutions to help farmers and to grow the agricultural industry in Indonesia. With a long history of operating in Indonesia, Bayer fully supports the Indonesian Government’s efforts towards achieving self-sufficiency in rice, and we are leading the Rice working group under the Partnership for Indonesia Sustainable Agriculture (PISAgro) which was launched to accelerate the development of sustainable agricultural practices in the country,” said Eric Tesson, Country Head for Bayer CropScience Indonesia.
“With the majority of rice farmers in Indonesia being smallholders, many of them do not have access to technologies to help them with better and more efficient rice cultivation. We have introduced Bayer Tabela, a proprietary direct seeding technology, to help reduce labour and water requirements. We are now excited to bring our Arize® hybrid rice seeds to the market to help farmers increase their yields, while at the same time, protect their crops from BLB, a much dreaded disease especially in the wet season,” he added.
In Indonesia, BLB currently affects 6 to 7 million hectares of rice annually, causing yield losses of as much as 80 per cent. The disease can afflict the rice plant during any of its growing stages, and causes visible wilting of seedlings, yellowing and drying of leaves, depending on the severity of the disease and the crop stage at the time of infection. The situation is a key challenge for Indonesian farmers as there is currently no effective chemical treatment in the market.
With the capability to ensure higher yields and protection against BLB, Arize® H6444 Gold is already a success in neighbouring countries including India, Vietnam, Philippines and Bangladesh, and will provide a much needed solution for Indonesian farmers to combat BLB and contribute towards the country’s quest for higher rice production.
Going forward, Bayer is working on bringing more hybrids with increased tolerance to the Brown Plant Hopper (BPH), submergence and salinity, as well as blast.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care and agriculture. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 9,494 million (2014) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 23,100 and is represented in more than 120 countries. This and further news is available at: www.bayercropscience.com.
Asia: Lynn Ong, Tel.: +65 6496 1797 / +65 9834 2351
Indonesia: Anton Susanto, Tel.: +62 21 3049 1506
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.